ESMOCARD

This brand name is authorized in Croatia, Estonia, France, Ireland, Lithuania, Poland, South Africa.

Active ingredients

The drug ESMOCARD contains one active pharmaceutical ingredient (API):

1
UNII V05260LC8D - ESMOLOL HYDROCHLORIDE
 

Esmolol is a beta-selective (cardioselective) receptor blocking agent. At therapeutic doses esmolol has no significant intrinsic sympathicomimetic activity (ISA) or membrane stabilising activity.
 
Read more about Esmolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C07AB09 Esmolol C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1253089, 1436824, 1491285
FR Base de données publique des médicaments 65388426, 65650469
HR Agencija za lijekove i medicinske proizvode HR-H-243481564
LT Valstybinė vaistų kontrolės tarnyba 1023314, 1050542
PL Rejestru Produktów Leczniczych 100197583, 100197590, 100243290
ZA Health Products Regulatory Authority 45/5.2/0806

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈